Melphalan and Ipratropium bromide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Melphalan (melphalan) and Ipratropium bromide (ipratropium bromide). Common drug interactions include acute left ventricular failure among females and septic shock among males.

The phase IV clinical study analyzes what interactions people have when they take Melphalan and Ipratropium bromide. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Melphalan?

Melphalan has active ingredients of melphalan. eHealthMe is studying from 20,052 Melphalan users. Check the latest studies of Melphalan.

What is Ipratropium bromide?

Ipratropium bromide has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 17,965 Ipratropium bromide users. Check the latest studies of Ipratropium bromide.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 14, 2026

17 people who take Melphalan and Ipratropium bromide together, and have interactions are studied.

Melphalan and Ipratropium bromide drug interactions.

What are the common drug interactions of Melphalan and Ipratropium Bromide, by gender? *:

female:

Acute left ventricular failure (heart attack)
Renal failure (kidney dysfunction)
Lung infection
Pneumonia

male:

Septic shock (shock due to blood infection)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Hypokalaemia (low potassium)
Lactic acidosis (low ph in body tissues)
Neutropenia (an abnormally low number of neutrophils)
Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
Benign prostatic hyperplasia (benign enlargement of the prostate)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Coagulopathy (blood's ability to clot is impaired)
Phlebitis (inflammation of the walls of a vein)

What are the common drug interactions of Melphalan and Ipratropium Bromide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Lower limb fracture
Pneumonia pseudomonal (pseudomonas pneumonia is an infection caused by the microbe known as pseudomonas aeruginosa)
Septic shock (shock due to blood infection)
Urinary tract infection pseudomonal

60+:

Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Pneumonia
Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
Anaemia (lack of blood)
Benign prostatic hyperplasia (benign enlargement of the prostate)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Coagulopathy (blood's ability to clot is impaired)
Oedema peripheral (superficial swelling)
Phlebitis (inflammation of the walls of a vein)
Platelet count decreased

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 16 people, 94.12%
Fever: 6 people, 35.29%
Insomnia (sleeplessness): 4 people, 23.53%
Bronchitis Chronic (inflammation of the mucous membrane in the bronchial tubes- chronic): 4 people, 23.53%
Dyspnea (difficult or laboured breathing): 3 people, 17.65%
Fluid Retention (an abnormal accumulation of fluid in the blood): 3 people, 17.65%
Cardiac Failure: 3 people, 17.65%
Delirium (wild excitement): 3 people, 17.65%
Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 3 people, 17.65%
Constipation: 3 people, 17.65%

* Approximation only. Some reports may have incomplete information.

Do you take Melphalan and Ipratropium bromide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously